|
NETO2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.62436730732907E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
<1E-12 |
| Normal-vs-Stage2 |
1.74538161701321E-12 |
| Normal-vs-Stage3 |
1.62447832963153E-12 |
| Normal-vs-Stage4 |
1.62436730732907E-12 |
| Stage1-vs-Stage2 |
9.363400E-01 |
| Stage1-vs-Stage3 |
8.483000E-01 |
| Stage1-vs-Stage4 |
2.045000E-01 |
| Stage2-vs-Stage3 |
8.455800E-01 |
| Stage2-vs-Stage4 |
3.542400E-01 |
| Stage3-vs-Stage4 |
3.234000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
2.45750086946828E-11 |
| Normal-vs-Asian |
1.099920E-02 |
| Caucasian-vs-AfricanAmerican |
2.16589999999517E-05 |
| Caucasian-vs-Asian |
2.749400E-01 |
| AfricanAmerican-vs-Asian |
5.134000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62436730732907E-12 |
| Normal-vs-Female |
<1E-12 |
| Male-vs-Female |
6.349700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.55320000000603E-06 |
| Normal-vs-Age(41-60Yrs) |
<1E-12 |
| Normal-vs-Age(61-80Yrs) |
1.62447832963153E-12 |
| Normal-vs-Age(81-100Yrs) |
6.37620000021322E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.205200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.144200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.536400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.580210E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.149400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.760800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.27479999995273E-06 |
| Normal-vs-Grade 2 |
1.62436730732907E-12 |
| Normal-vs-Grade 3 |
<1E-12 |
| Normal-vs-Grade 4 |
<1E-12 |
| Grade 1-vs-Grade 2 |
2.754400E-01 |
| Grade 1-vs-Grade 3 |
7.958200E-02 |
| Grade 1-vs-Grade 4 |
8.837700E-03 |
| Grade 2-vs-Grade 3 |
1.630440E-01 |
| Grade 2-vs-Grade 4 |
4.222900E-03 |
| Grade 3-vs-Grade 4 |
3.757500E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.62447832963153E-12 |
| Normal-vs-ccB subtype |
<1E-12 |
| ccA subtype-vs-ccB subtype |
4.7406000014405E-08 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.62447832963153E-12 |
| Normal-vs-N1 |
5.97449999999444E-05 |
| N0-vs-N1 |
1.931170E-01 |
|
|
